Anti-reflux mucosal ablation significantly benefits patients with reflux-predominant GERD unresponsive to PPI therapy. 71.4% of patients receiving mucosal ablation reported at least a 50% improvement in quality of life after 6 months, compared to just 3.6% in the sham group (p<0.001). Significant reductions in heartburn, regurgitation, and reflux episodes were observed, with 35.7% of patients […]
Category: General Surgery
Endoscopic Submucosal Dissection Effective for Rectal Neoplasms
Endoscopic submucosal dissection (ESD) shows promise for safely resecting rectal neoplasms near the dentate line, improving surgical options. En bloc resection rates reached 93.7% and R0 resection rates were at 85.4% in 255 patients. Overall adverse events occurred in just 8.7%, with manageable complications like bleeding (5.1%). This technique could replace traditional transanal methods, but […]
Emerging Techniques for GERD: Long-Term Efficacy Insights
Novel minimally invasive procedures for gastroesophageal reflux disease show promising outcomes, impacting patient selection and surgical approaches. Esophyx and Linx provide long-lasting symptom relief, with sustained quality of life improvements for chronic GERD patients. Stretta shows clinically significant long-term effects on proton pump inhibitor usage and pH monitoring but has limited follow-up data. Surgeons should […]
Predicting Liver Failure After Hepatectomy: Key Early Indicators
Early liver function tests can help surgeons identify patients at risk for post-hepatectomy liver failure (PHLF), improving outcomes. In a study of 445 patients, 8.5% developed PHLF. On postoperative day 3, bilirubin ≥1.8 mg/dl (sensitivity 93.3%) and INR ≥1.18 (sensitivity 80.6%) strongly predicted PHLF. Relying on current guidelines starting at day 5 could delay important […]
Preoperative A1C Screening Critical for Surgery Outcomes
Elevated preoperative hemoglobin A1C is linked to higher postoperative complications in general surgery. 36% of patients had diagnosed diabetes; 6.4% had undiagnosed diabetes with A1C levels indicating the condition. Complications risk increased with A1C levels: from 1.06 for <6.0% to 1.32 for >9.0%. Undiagnosed diabetes led to 24% higher mortality risk and 11% higher risk […]
Social Factors Impact Post-Gastrectomy Outcomes in Cancer Patients
Social determinants significantly affect short-term outcomes after gastrectomy for gastric adenocarcinoma, highlighting disparities in care. Black patients are 25% less likely and Hispanic patients are 29% less likely to experience extended hospital stays compared to white patients. Higher education levels correlate with a 19% increased risk of extended stays and a 26% increased risk of […]
Bile Duct Injury Repair Insights: Delayed is Safer
Delayed repair for bile duct injuries (BDIs) following cholecystectomy significantly lowers reoperation and mortality rates. Early repair increases reoperation rates by 3.31 times and stricture rates by 7.41 times compared to late repair. Non-operative management leads to a staggering 16.60 higher reoperation rate than operative interventions. Surgeons should prioritize delayed repair to improve patient outcomes […]
Early FAST Ultrasound Cuts Trauma Mortality in Low-Resource Settings
Using early FAST ultrasound drastically lowers mortality rates in severe trauma patients, proving essential in low-resource environments. In-hospital mortality: 39.2% with FAST vs. 66.2% without (p=0.001). Thirty-day mortality: 45.6% with FAST vs. 72.7% without (p=0.001). Integrating FAST into trauma triage can enhance surgical outcomes significantly. Reduced CT scans (82.5% with FAST vs. 96.1% without, p=0.006) […]
Multimodal Advances Transforming Gastric Cancer Management
Recent updates in multimodal treatment are reshaping gastric cancer care, impacting surgical strategies and patient outcomes. Laparoscopic and robotic gastrectomy are now standard in Asia, supported by major trials like JCOG0912 and K-LASS02. The FLOT chemotherapy regimen is becoming the global standard, while SOX and XELOX gain traction in Asia. Surgeons should consider integrating immunotherapy […]
Efficacy of HIPEC After Laparoscopic Gastrectomy in Gastric Cancer
Laparoscopic gastrectomy plus hyperthermic intraperitoneal chemotherapy (HIPEC) improves outcomes for gastric cancer patients with positive peritoneal lavage cytology. HIPEC-treated patients had significantly lower postoperative recurrence (66.7% vs. 90.9%) and visible metastasis (29.6% vs. 59.1%, p < 0.05). 3-year overall survival for HIPEC patients was 51.8% versus 18.2% for non-HIPEC (p = 0.005). Consider HIPEC for […]